光化性角化病(AK)是浅色皮肤个体的常见病变,可能会发展为皮肤鳞状细胞癌(cSCC)。这两种情况都可能与显著的发病率相关,并构成主要的疾病负担。尤其是老年人。建立基于证据的临床决策框架,指南"光化性角化病和皮肤鳞状细胞癌"在主题皮肤鳞状细胞原位癌(Bowen病)和光化性唇炎中得到了更新和扩展.该指南针对皮肤科医生,全科医生,耳鼻喉专家,外科医生,肿瘤学家,医院和办公室环境中的放射科医生和放射肿瘤学家,以及其他医学专业,参与AK和cSCC患者诊断和治疗的政策制定者和保险基金。对于患者及其亲属存在单独的指南。在这一部分,我们将讨论与AK有关的方面,光化性唇炎,Bowen病,职业病和护理结构。
Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the
guideline “actinic keratosis and cutaneous squamous cell carcinoma” was updated and expanded by the topics cutaneous squamous cell carcinoma in situ (Bowen\'s disease) and actinic
cheilitis. The
guideline is aimed at dermatologists, general practitioners, ear nose and throat specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings, as well as other medical specialties, policy makers and insurance funds involved in the diagnosis and treatment of patients with AK and cSCC. A separate
guideline exists for patients and their relatives. In this part, we will address aspects relating to AK, actinic
cheilitis, Bowen\'s disease, occupational disease and care structures.